metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology O-17 NUTRICIONAL AND PHYSICAL THERAPHY IMPROVES LIVER FRAILTY INDEX IN LISTED PA...
Journal Information
Vol. 29. Issue S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(February 2024)
Share
Share
Download PDF
More article options
Vol. 29. Issue S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(February 2024)
Full text access
O-17 NUTRICIONAL AND PHYSICAL THERAPHY IMPROVES LIVER FRAILTY INDEX IN LISTED PATIENTS WITH CIRRHOSIS: RANDOMIZED CONTROLLED TRIAL. INTERIM ANALYSIS
Visits
245
Diego Reyes1, Carlos Benitez1, Anny Galvez2, Catalina Grandy1, Nicolás Lavados3, Isidora Cerda4, Nicole Kim1, Lucas Lacalle1, Sebastián Rosales1, Eduardo Fuentez-López1, Francisco Cerda1, Silvana Valdés1, Valeria Cuzmar1, Soledad Contreras5, Teresita Risopatrón5, Roberto Candia1
1 Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
2 Instituto de Trasplante, Instituto de Trasplante, Red de Salud UC Christus, Santiago, Chile
3 Escuela de Medicina, Facultad de Medicina, Universidad de Chile, Santiago, Chile
4 Escuela de Medicina, Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile
5 Programa de Medicina Física y Rehabilitación, Red de Salud UC Christus, Santiago, Chile
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Figures (1)
Special issue
This article is part of special issue:
Vol. 29. Issue S1

Abstracts of the 2023 Annual Meeting of the ALEH

More info
Introduction and Objectives

Frailty is independently associated with a lower survival in cirrhotic patients. Liver Frailty Index (LFI) determine frailty in listed patients predicting survival. This study aimed to evaluate the effect of a physical and nutritional therapy (intervention group) over LFI compared with a physical and nutritional counseling (control group).

Materials and Methods

Patients were recruited and randomized to an intervention group or a control group. Patients were followed for 12 weeks with evaluations every 4 weeks. We compared LFI and LFI at different time points between both groups during the follow-up.

Results

46 patients were recruited, 27 of them in control group and 19 of them in the intervention group. 50% were women and the most common etiologies were metabolic associated fatty liver disease (37%) and alcoholic liver disease (19.6%), primary biliary cholangitis (6.52%), autoimmune hepatitis (6.52%) and hepatitis C virus (2.17%). The median (IQR) age was 60 years (53-63 years), MELD-Na 17 (15-21), creatinine 0.75 mg/dl (0.6-0.8) albumin 3.1 g/dl (2.9-3.1), INR 1.54 (1.4-1.75) and bilirubin 2.6 mg/dl (1.4-1.7). Child-Pugh scores were A/B/C 13%/58.7%/28.3% respectively. No differences in baseline characteristics were found between the groups. Notably, there was a significant improvement in LFI (median; IQR) in the intervention group (Figure 1) after 8 weeks LFI 3.74 (3.37-3.97) with LFI -0.86 vs. control group LFI 4.15 (3.94-4.23) with LFI -0.02, p=0.007) and after 12 weeks (intervention group 3.73 (3.31-4.11) with LFI -0.87 vs. control group LFI 4.14 (4.06-4.50) with LFI -0.03, p=0.023).

Conclusions

In this interim analysis nutritional and physical therapy improves LFI. This is the first randomized controlled trial with positive results in listed patients with cirrhosis.

Full Text

Figure 1. LFI of control group (0) and intervention group (1). LFI_E0: Baseline LFI; LFI_E1: LFI after 4 weeks; LFI_E2: LFI after 8 weeks. LFI_E3: LFI after 12 weeks.

Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos